These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4777246)

  • 1. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
    Huang JT; Ho BT
    Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of rigid amphetamine analogs on vascular strips: studies of 2-aminotetrahydronaphthalene and 2-aminoindan derivatives.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF; Rusterholz DB
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):264-73. PubMed ID: 4851775
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
    Buyniski JP; Smith ML; Bierwagen ME
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of d- and l-amphetamine on 5-hydroxytryptamine receptors.
    Cheng HC; Long JP
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):124-31. PubMed ID: 4746623
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of fenfluramine, 2,5-dimethoxy-4-methyl amphetamine (DOM) and D-amphetamine on the concentration of serotonin and some free amino acids in the suboesophageal ganglia of Helix pomatia.
    Osborne NN; Neuhoff V; Leonard BE
    Z Naturforsch C Biosci; 1974; 29(3):189-90. PubMed ID: 4276702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiovascular effects of 2,5-dimethoxy-4-methyl amphetamine (S.T.P. or D.O.M.)].
    Boissier JR; Advenier C; Giudicelli JF
    Therapie; 1972; 27(6):989-99. PubMed ID: 4661229
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pressor action of 2,5-dimethoxy-4-methylamphetamine in rats.
    Huang J; Beng TH
    J Pharm Pharmacol; 1972 Aug; 24(8):656-7. PubMed ID: 4403750
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
    Penington NJ; Reiffenstein RJ
    Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 12. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP).
    Cheng HC; Long JP; Barfknecht CF; Nichols DE
    J Pharmacol Exp Ther; 1973 Aug; 186(2):345-54. PubMed ID: 4719787
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 17. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 18. EEG and behavioral effects of 2-5-methoxy-4-methyl-amphetamine (DOM, STP).
    Florio V; Lipparini F; Scotti de Carolis A; Longo VG
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):81-8. PubMed ID: 5357012
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cinanserin and p-chlorophenylalanine and their interaction with d-amphetamine on DRL performance in rats.
    Mele PC; Caplan MA
    Pharmacol Biochem Behav; 1980 Jun; 12(6):883-91. PubMed ID: 6447298
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
    Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
    J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.